Here we are, six months into the year and the front-runners in the limited series categories remain the same shows we watched and loved from 2021 — HBO's sharp satire of entitlement, "The White Lotus" (which premiered nearly a year ago) and two series from October, Netflix's intimate drama "Maid" and Hulu's heroic "Dopesick." You've already heard "Dopesick" star Michael Keaton deliver a couple of moving speeches while accepting awards for his poignant work in the series. He'll likely give another one at the Emmys as well.
All this is rather surprising, given the number of splashy limited series that networks and streamers dumped on audiences before the May 31 Emmys eligibility deadline. These shows boasted such A-list stars as Viola Davis, Gillian Anderson ("The First Lady"), Andrew Garfield ("Under the Banner of Heaven") and Julia Roberts and Sean Penn ("Gaslit"). HBO gave us a terrific true-crime series starring Colin Firth ("The Staircase"). There were in-depth examinations of the rise and fall of Theranos ("The Dropout") and WeWork ("WeCrashed") and ... and ... and ... you get the picture.
Maybe the reason the early favorites remain the favorites is that voters couldn't possibly have the time, energy or (let's be honest) the inclination to delve into all these titles that arrived around the same time.
